Doctors’ Advice on Weight Loss Tablets

Struggling to lose weight despite strict dieting and intense workouts? A major breakthrough may offer relief. The United Kingdom has officially approved a revolutionary weight loss tablet on June 11, 2026, eliminating the need for painful injections. Developed by Novo Nordisk, this oral medication had already received approval in the United States and is now creating global optimism among people battling obesity. The pill contains semaglutide, the same active ingredient found in Ozempic injections used for diabetes treatment, making it a promising alternative for those hesitant about injectable therapies.

The global weight loss drug market is witnessing rapid expansion, with pharmaceutical companies racing to innovate. Competing with Novo Nordisk, Eli Lilly has also introduced its oral drug “Foundayo” earlier this year. Experts estimate the market could exceed $100 billion by 2030. According to Dr. Mary Spreckley from the University of Cambridge, oral tablets may be more effective for certain patients compared to injections. She advises taking the pill on an empty stomach at least 30 minutes before meals for optimal results. While this development brings hope to millions, medical consultation remains essential before starting any treatment.

Note: This information is provided for awareness purposes only. If you have any health issues or doubts, please consult a doctor and follow their advice accordingly.